Sarcopenia, Aging
Conditions
Keywords
Sarcopenia, Aging, Biomarkers, Metabolomics
Brief summary
With the rapid growth of the global elderly population, the studies of the biomarkers of the sarcopenia and aging are under investigation in different ways. The investigators use Metabolomics to explore the biomarkers of the sarcopenia and aging of the senior adults.
Detailed description
Metabolomics is the emerging platform technology to address the complexity of a living system. In translational research, metabolomics approaches may enable the detection of multiple disease risk factors and interactions, disease progression, and response of patients to a particular therapy with or without side effects. Metabolomics may provide comprehensive information and improve diagnosis and prognosis which are particularly promising in human complex degenerative diseases. The investigators use Metabolomics to explore the biomarkers of the sarcopenia and aging of the senior adults.
Interventions
DIAGNOSTIC_TESTblood and urine sampling
Ten mL blood and 15mL urine are collected.
Sponsors
Chang Gung University
Chang Gung Memorial Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* residents of the Chang Gung Health and Culture Village * mostly independent and do not require nursing assistance * capable of managing their daily living activities * aged ≧ 60
Exclusion criteria
* None.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The biomarkers of the sarcopenia and aging in senior adults. | one year | Metabolomics to explore the biomarkers of the sarcopenia and aging. |
Countries
Taiwan
Contacts
Primary ContactChih-Ming Lin, M.D.
Outcome results
None listed